Newsletter number 32 - April 2012
This newsletter contains articles on the following subjects:

• Revocation due to lack of inventive step of Pfizer patent on polymorph of magnesium atrovastatin.
• Bad faith, nullity of marks and infringement: Nuances of the CTM Court criteria.
• The defendant’s lack of cooperation cannot benefit him when quantifying the damages.
• Condemnatory Judgment in a criminal case of imitation of a well-known trademark, the importer having invoked a cover registration.

Alternatively, if you would like to see any of our archive newsletters, simply select the relevant article from the drop-down list below.

Archive newsletters... Newsletter 32 - April 2012Newsletter 31 - January 2012Newsletter 30 - October 2011Newsletter 29 - July 2011Newsletter 28 - - April 2011Newsletter 27 - January 2011Newsletter 26 - October 2010Newsletter 25 - July 2010Newsletter 24 - April 2010Newsletter 23 - January 2010Newsletter 22 - October 2009Newsletter 21 - July 2009Newsletter 20 - April 2009Newsletter 19 - October 2008Newsletter 18 - July 2008Newsletter 17 - April 2008Newsletter 16 - January 2008Newsletter 15 - October 2007Newsletter 14 - July 2007Newsletter 13 - April 2007Newsletter 12 - January 2007Newsletter 11 - October 2006Newsletter 10 - July 2006Newsletter 9 - April 2006Newsletter 8 - January 2006Newsletter 7 - October 2005Newsletter 6 - July 2005Newsletter 5 - April 2005Newsletter 4 - January 2005Newsletter 3 - October 2004Newsletter 2 - July 2004Newsletter 1 - April 2004